Non-Vascular Stents - APAC Analysis and Market Forecasts

Transcription

1 Non-Vascular Stents - APAC Analysis and Market Forecasts

2 Non-Vascular Stents - APAC Analysis and Market Forecasts BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen years. BioPortfolio offers a personal service to our customers with dedicated research managers who will work with you to source the best report for your needs. Based in the UK, BioPortfolio is well positioned to coordinate our customers' orders sourced from over 50 global report publishers. We are pleased to present details of this report to assist your buying decision and administrative process. You will find easy-to-use How To Buy information on the last page of this document. We look forward to being of service to you. If you have bulk and/or recurring requirements, please get in touch - we can liaise with publishers to obtain sample pages and negotiate discounts on your behalf. Phone: +44 (0) or reportstore@bioportfolio.com 2

3 Non-Vascular Stents - APAC Analysis and Market Forecasts Non-Vascular Stents - APAC Analysis and Market Forecasts Summary Non-vascular stent technology has evolved over the years such that these devices are routinely used in clinical practice for different indications. Although it is a mature market, both short and long-term complications associated with non-vascular stents continue to persist. This report focuses on four market categories within the non-vascular stent segment, which includes enteral stents (esophageal, gastroduodenal and colonic stents), pancreatic and biliary stents, airways stents and urinary tract stents (ureteral, prostate and urethral stents). The overall non-vascular stent market has been estimated in this report, which covers the Japan, China and India up to The report provides an investigation of unmet needs, future adoption trends and compound annual growth rates (CAGR) for each geography and market segment. In addition, this report presents the current market drivers and barriers which will influence the future market growth of non-vascular stents in APAC. *This is an on-demand report and will be delivered within 4 working days (excluding weekends) of the purchase. Highlights Key Questions Answered - (Q). What is the current and future non-vascular stent market outlook in the developed and emerging markets? (Q). What trends are affecting the global non-vascular stents market? - (Q). Which are the key, high growth markets that stent manufacturers should expand into? (Q). What nonvascular stent segments are growing the fastest? - There are a few significant unmet needs. (Q). What are these unmet needs? (Q). What is the scope for more innovation and what are the end-users looking for in their products? - (Q). Will biodegradable stent systems fulfill these unmet needs? (Q). What is physician perception and market outlook of this technology? - (Q). What percent of global profits are from emerging markets? (Q). How will this change in the future? - Boston Scientific currently dominates the global non-vascular stents market. (Q). What is their market share in the major global economies and which companies constitute the remainder of the market? Reasons to buy - What Physicians Think quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. In this report you will understand the perceptions of leading physicians and other stakeholders from around the world. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information. 3

4 Additional Details Publisher : Global Data Reference : GDME1139CFR Number of Pages : 0 Report Format : PDF Publisher Information : 4

5 Table Of Contents for Non-Vascular Stents - APAC Analysis and Market Forecasts 1 Table of Contents1.1 List of Tables1.2 List of Figures2 Introduction2.1 Catalyst2.2 Related Reports3 Industry Overview3.1 Overview3.2 Non-Vascular Stenting Indications3.2.1 Enteral Stents3.2.2 Pancreatic and Biliary Stents3.2.3 Airway Stents3.2.4 Urinary Tract Stents3.3 Types of Stents and Clinical Efficacy3.3.1 Enteral Stents3.3.2 Pancreatic and Biliary Stents3.3.3 Airway Stents3.3.4 Urinary Tract Stents3.4 Procedure Trends3.4.1 Asia-Pacific3.5 Market Access3.5.1 Product Adoption3.5.2 Regulation3.5.3 Reimbursement3.6 Regulatory Issues/Recalls ( )3.6.1 Cordis Corporation Class II Recall of S.M.A.R.T Control Transhepatic Biliary Stent3.7 Mergers, Acquisitions, and Other Deals3.7.1 Medtronic Acquires Covidien3.7.2 Beijing King Health Signs Distribution Agreement With Allium Medical3.7.3 Cordis Acquires Flexible Stenting Solutions3.7.4 Allium Medical Enters Into Distribution Agreement With Meizler UCB Biopharma3.7.5 Gore and ConMed Extend Distribution Agreement3.7.6 Allium Medical Acquires Gardia Medical3.7.7 Flexible Stenting Solutions Raises Funds in Series B Financing3.8 Economic Impact4 Unmet Needs4.1 Addressing the Complications4.1.1 Enteral Stents4.1.2 Pancreatic and Biliary Stents4.1.3 Airway Stents4.1.4 Urinary Tract Stents4.2 Overcoming Stent Design Challenges4.2.1 Stent Shortening4.2.2 Stent Fracture4.2.3 Flexibility4.3 Simplify Delivery Systems4.4 Disconnect Between Industry and Physicians4.5 Indication-Specific Stents4.6 Lack of Long-Term and Comparative Clinical Data4.7 Refocus on Pipeline Products4.8 Lack of Standardization4.9 Cost-Containment4.10 Need for An International Procedure Registry5 Market Opportunity Analysis5.1 Improve Stent Systems5.2 Biodegradable Stents5.3 Drug-Eluting Stents5.4 Radiosensitization5.5 Customized Stents5.6 Emerging Markets6 Market Drivers and Barriers6.1 Driver: Rising Disease Prevalence6.1.1 Cancer6.1.2 Urolithiasis6.2 Driver: Non-Malignant Stenting Applications to Drive the Market6.2.1 Drainage6.2.2 Bariatric Surgery6.2.3 Neoadjuvant Treatment6.2.4 Benign Strictures6.3 Driver: Fully-Covered, Removable Metal Stents To Drive Future Growth6.4 Driver: Preference for Minimally-Invasive Solutions6.5 Driver: Increased Life Expectancy6.6 Driver: Technological Advancements6.7 Driver: Patient Demand and Awareness6.8 Driver: Rising Competition and Innovation6.9 Barrier: Availability of Venture Capital6.10 Barrier: Burden of Rising Regulation6.11 Barrier: Proving Long-Term Efficacy6.12 Barrier: Medical Device Excise Tax7 Competitive Assessment7.1 Gastrointestinal Stents7.1.1 Overview7.1.2 WallFlex (Boston Scientific Corporation)7.1.3 Evolution (Cook Medical)7.1.4 Niti-S (Taewoong Medical)7.1.5 Other Key Marketed Gastrointestinal Stents7.2 Biliary Stents7.2.1 Overview7.2.2 WallFlex Biliary RX (Boston Scientific Corporation)7.2.3 Cotton-Leung (Amsterdam) (Cook Medical)7.2.4 Bonastent (EndoChoice)7.2.5 Other Key Marketed Biliary Stents7.3 Airway Stents7.3.1 Overview7.3.2 Dumon (Novatech)7.3.3 Aero/Aero DV (Merit Endotek)7.3.4 Ultraflex (Boston Scientific Corporation)7.3.5 Other Key Marketed Airway Stents7.4 Urinary Tract Stents7.4.1 Overview7.4.2 Polaris Ultra (Boston Scientific Corporation)7.4.3 InLay Optima (C.R. Bard)7.4.4 Other Key Marketed Urinary Tract Stents8 Clinical Trials to Watch8.1 Overview8.2 Enteral Stents8.3 Pancreatic and Biliary Stents8.4 Airway Stents8.5 Urinary Tract Stents9 Current and Future Players9.1 Trends in Corporate Strategy9.2 Company Profiles9.2.1 Allium Medical9.2.2 Boston Scientific Corporation9.2.3 ConMed9.2.4 Cook Medical9.2.5 C.R. Bard9.2.6 Ella-CS9.2.7 Merit Endotek9.2.8 M.I. Tech9.2.9 Micro-Tech (Nanjing) Medtronic (Covidien) Novatech Olympus Taewoong Medical Xlumena Other Companies10 Market Outlook10.1 Company Market Share Asia-Pacific10.2 By Market Segment Global Overview Enteral Stents Pancreatic and Biliary Stents Airway Stents Urinary Tract Stents10.3 By Geography Asia-Pacific11 Appendix11.1 Bibliography11.2 Abbreviations11.3 Research Methodology Overview Coverage Secondary Research11.4 Physicians and Specialists Included in this Study11.5 Primary Research Primary Research Key Opinion Leader Interviews Primary Research Physician and Industry Interviews Expert Panel Validation11.6 Forecasting Methodology11.7 About the Authors Analysts Global Head of Healthcare11.8 About MediPoint11.9 About GlobalData11.10 Disclaimer 5

6 List Of Tables in Non-Vascular Stents - APAC Analysis and Market Forecasts 1.1 List of Tables Table 1: Ideal Characteristics of a Stent Table 2: Comparison of Silicone and Metal Airway Stents Table 3: Enteral Stenting Procedure Volumes Forecast for APAC, Table 4: Pancreatic and Biliary Stents Procedure Volumes Forecast for APAC, Table 5: Airway Stenting Procedure Volumes Forecast for APAC, Table 6: Urinary Tract Stenting Procedure Volumes Forecast for APAC, Table 7: Medicare National Average Reimbursement Rates for Non-Vascular Stenting Procedures, 2014 Table 8: Direct, Indirect, and Intangible Costs of Non-Vascular Stenting Table 9: WallFlex Family Stent Product Portfolio Table 10: WallFlex Stent Family SWOT Analysis Table 11: Evolution Family Stent Product Portfolio Table 12: Evolution Stent Family SWOT Analysis Table 13: Niti-S Family Stent Product Portfolio Table 14: Niti-S Stent Family SWOT Analysis Table 15: Gastrointestinal Stents, Other Key Marketed Products Table 16: WallFlex Biliary RX Stent Product Portfolio Table 17: WallFlex Biliary RX Stent SWOT Analysis Table 18: Cotton-Leung Stent Product Portfolio Table 19: Cotton-Leung Stent SWOT Analysis Table 20: Bonastent Product Portfolio Table 21: Bonastent Stent SWOT Analysis Table 22: Biliary Stents, Other Key Marketed Products Table 23: Dumon Stent Product Portfolio Table 24: Dumon Stent SWOT Analysis Table 25: Aero/Aero DV Stent Product Portfolio Table 26: Aero/Aero DV Stents SWOT Analysis Table 27: Ultraflex Stent Product Portfolio 6

7 Table 28: Ultraflex Stent SWOT Analysis Table 29: Airway Stents, Other Key Marketed Products Table 30: Polaris Ultra Stent Product Portfolio Table 31: Polaris Ultra Stent SWOT Analysis Table 32: InLay Optima Stent Product Portfolio Table 33: InLay Optima SWOT Analysis Table 34: Urinary Tract Stents, Other Key Marketed Products Table 35: Major Clinical Trials for Enteral Stents Table 36: Major Clinical Trials for Pancreatic and Biliary Stents Table 37: Major Clinical Trial for Airway Stents Table 38: Company Profile Allium Medical Table 39: Allium Medical s Marketed Non-Vascular Stent Products Table 40: SWOT Analysis Allium Medical Table 41: Company Profile Boston Scientific Corporation Table 42: Boston Scientific Corporation s Marketed Non-Vascular Stent Products Table 43: SWOT Analysis Boston Scientific Corporation Table 44: Company Profile ConMed Table 45: ConMed, Key Marketed Non-Vascular Stent Products Table 46: SWOT Analysis ConMed Table 47: Company Profile Cook Medical Table 48: Cook Medical, Key Marketed Non-Vascular Stent Products Table 49: SWOT Analysis Cook Medical Table 50: Company Profile C.R. Bard Table 51: C.R. Bard, Key Marketed Non-Vascular Stent Products Table 52: SWOT Analysis C.R. Bard Table 53: Company Profile Ella-CS Table 54: Ella-CS, Key Marketed Non-Vascular Stent Products Table 55: SWOT Analysis Ella-CS Table 56: Company Profile Merit Endotek Table 57: Merit Endotek s Key Marketed Non-Vascular Stent Products Table 58: SWOT Analysis Merit Endotek 7

8 Table 59: SWOT Analysis M.I. Tech Table 60: Company Profile Micro-Tech (Nanjing) Table 61: Micro-Tech (Nanjing), Key Marketed Non- Vascular Stent Products Table 62: SWOT Analysis Micro-Tech (Nanjing) Table 63: Medtronic (Covidien) Marketed Non-Vascular Stent Products Table 64: SWOT Analysis Medtronic (Covidien) Table 65: Company Profile Novatech Table 66: Novatech s Marketed Non-Vascular Stent Products Table 67: SWOT Analysis Novatech Table 68: Company Profile Olympus Table 69: Olympus Key Marketed Non-Vascular Stent Products Table 70: SWOT Analysis Olympus Table 71: Company Profile Taewoong Medical Table 72: Taewoong Medical Marketed Products Table 73: SWOT Analysis Taewoong Medical Table 74: Company Profile Xlumena Table 75: Xlumena s Key Marketed Non-Vascular Stent Products Table 76: SWOT Analysis Xlumena Table 77: Other Companies Involved in the Non-Vascular Stents Market, 2014 Table 78: Non-Vascular Stents Sales ($m) Forecast for APAC, Table 79: Non-Vascular Stents Sales ($m) Forecast for Japan, Table 80: Non-Vascular Stents Sales ($m) Forecast for China, Table 81: Non-Vascular Stents Sales ($m) Forecast for India, Table 82: Non-Vascular Stents - Primary Call Count by Country Table 83: Non-Vascular Stents - Primary Call Count by Type 8

9 List Of Figures, Charts and Diagrams in Non-Vascular Stents - APAC Analysis and Market Forecasts 1.2 List of Figures Figure 1: Enteral Stent Esophageal Figure 2: Biliary Stent Figure 3: Bronchial Stent Figure 4: Prostatic and Urethral Stents Figure 5: Development Timeline for Esophageal Stents Figure 6: Development Timeline for Gastroduodenal Stents Figure 7: Development Timeline for Colorectal Stents Figure 8: Enteral Stenting Procedure Volumes Forecast for APAC, Figure 9: Enteral Stenting Procedure Volumes Forecast for APAC By Stent Type, 2013 and 2021 Figure 10: Pancreatic and Biliary Stenting Procedure Volumes Forecast for APAC, Figure 11: Pancreatic and Biliary Stenting Procedure Volumes Forecast for APAC By Stent Type, 2013 and 2021 Figure 12: Airway Stenting Procedure Volumes Forecast for APAC, Figure 13: Airway Stenting Procedure Volumes Forecast for APAC By Stent Type, 2013 and 2021 Figure 14: Urinary Tract Stenting Procedure Volumes Forecast for APAC, Figure 15: Urinary Tract Stenting Procedures Forecast for APAC By Stent Type, 2013 and

10 How to Buy... Non-Vascular Stents - APAC Analysis and Market Forecasts Option 1 - Online Go to our website and pay online with any major debit or credit card: Option 2 - Request a Proforma Invoice Fill in the details below, and either Scan this page and it to us at reportstore@bioportfolio.com or Fax it to us at +44 (0) We will send you a Proforma Invoice and deliver your report on settlement. Your Name: Job Title: Your Your Contact Phone: Company Name: Address: Post/Zip Code: Country: P.O. Number: Any Other Instructions: Pricing Options: (please tick one) $4450 Single User Price $8900 Site License Price $11645 Enterprise License Price Payment Options: (please tick one) Online Credit Card (we will you the invoice with a payment link) Direct Wire Transfer (we will you the invoice with our bank details) Authorising Signature: Option 3 - Phone Us on +44 (0) We will be delighted to give you our personal attention. 10